Italy · Biotechnology startup

CoStim Pharmaceuticals

CoStim Pharmaceuticals Inc.

Funding reportedLast round: Series A

BiotechnologyItaly

About CoStim Pharmaceuticals

CoStim Pharmaceuticals Inc.

operates as a biotechnology company. It develops antibody agents for treatment of cancer. The company was

What company datasets say CoStim Pharmaceuticals raised

Funding, as reported

Reported in all22Min the source's currency
Rounds2
Last roundSeries A
Last round dateMar 2013
Investors listed4

Biotechnology in Italy

Startups like it

Is this your company?

Add your raise, your deck and your story, and put CoStim Pharmaceuticals in front of investors. Or tell us what we have wrong.